Literature DB >> 15148620

Arterio-embolic ischemic stroke in children with moyamoya disease.

Peter Horn1, Eva Bueltmann, Christoph V Buch, Peter Schmiedek.   

Abstract

INTRODUCTION: Moyamoya (MM) disease is a rare steno-occlusive cerebrovascular disease known to occur in children and adults. The most serious complications in children are developmental delay and mental retardation due to recurrent hemodynamic stroke. CASES: We report two pediatric patients without coagulopathy who suffered from severe arterio-embolic ischemic complications despite antiplatelet medication. DISCUSSION: These observations underline the potential impact of cerebral thromboembolism on the pathophysiology of the stroke and thus on the treatment of children with MM disease.

Entities:  

Mesh:

Year:  2004        PMID: 15148620     DOI: 10.1007/s00381-004-0962-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  10 in total

1.  Serial intelligence test scores in pediatric moyamoya disease.

Authors:  C Imaizumi; T Imaizumi; M Osawa; Y Fukuyama; M Takeshita
Journal:  Neuropediatrics       Date:  1999-12       Impact factor: 1.947

2.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

3.  Pathology of so-called "spontaneous occlusion of the circle of Willis".

Authors:  Y Hosoda
Journal:  Pathol Annu       Date:  1984

4.  Cerebral revascularization for moyamoya disease in children.

Authors:  K Houkin; S Kuroda; N Nakayama
Journal:  Neurosurg Clin N Am       Date:  2001-07       Impact factor: 2.509

5.  An indirect revascularization method in the surgical treatment of moyamoya disease--various kinds of indirect procedures and a multiple combined indirect procedure.

Authors:  T Matsushima; T Inoue; T Katsuta; Y Natori; S Suzuki; K Ikezaki; M Fukui
Journal:  Neurol Med Chir (Tokyo)       Date:  1998       Impact factor: 1.742

6.  Prothrombotic disorders in children with moyamoya syndrome.

Authors:  M Bonduel; M Hepner; G Sciuccati; A F Torres; S Tenembaum
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

7.  Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease).

Authors:  Y Hosoda; E Ikeda; S Hirose
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

8.  Prothrombotic abnormalities in children with venous thromboembolism.

Authors:  M Bonduel; M Hepner; G Sciuccati; A F Torres; G Pieroni; J P Frontroth
Journal:  J Pediatr Hematol Oncol       Date:  2000 Jan-Feb       Impact factor: 1.289

9.  Surgical treatment for paediatric patients with moyamoya disease by indirect revascularization procedures (EDAS, EMS, EMAS).

Authors:  T Matsushima; S Fujiwara; S Nagata; K Fujii; M Fukui; K Kitamura; K Hasuo
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

10.  Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children.

Authors:  T Kurokawa; S Tomita; K Ueda; O Narazaki; T Hanai; K Hasuo; T Matsushima; K Kitamura
Journal:  Pediatr Neurol       Date:  1985 Sep-Oct       Impact factor: 3.372

  10 in total
  3 in total

1.  The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; In Bo Han; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2014-08-07       Impact factor: 1.475

Review 2.  Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis.

Authors:  Jong S Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

3.  The Moyamoya Health Behavior Scale for Adolescent Patients: Measurement Tool Development and Psychometric Evaluation.

Authors:  Won-Oak Oh; Insun Yeom; Sung-Hyun Lim; Dong-Seok Kim; Kyu-Won Shim
Journal:  Int J Environ Res Public Health       Date:  2021-04-12       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.